Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 716

1.

A case report of mitochondrial respiratory chain disorder in the neonatal period for which home mechanical ventilation was introduced.

Sugimoto M, Togawa T, Aiba K, Koyama N, Yokochi K, Murayama K, Ohtake A.

No To Hattatsu. 2017 Jan;49(1):37-41. Japanese.

PMID:
30011153
2.

A unique increase in prefrontal gray matter volume in hoarding disorder compared to obsessive-compulsive disorder.

Yamada S, Nakao T, Ikari K, Kuwano M, Murayama K, Tomiyama H, Hasuzawa S, Togao O, Hiwatashi A, Kanba S.

PLoS One. 2018 Jul 16;13(7):e0200814. doi: 10.1371/journal.pone.0200814. eCollection 2018.

3.

Response to "infantile-onset deafness in m.7445A>G carriers may be multicausal".

Matsunaga T, Matsushima K, Murayama K.

Int J Pediatr Otorhinolaryngol. 2018 Aug;111:194. doi: 10.1016/j.ijporl.2018.06.023. Epub 2018 Jun 14. No abstract available.

PMID:
29934116
4.

Neural Correlates for Intrinsic Motivational Deficits of Schizophrenia; Implications for Therapeutics of Cognitive Impairment.

Takeda K, Sumiyoshi T, Matsumoto M, Murayama K, Ikezawa S, Matsumoto K, Nakagome K.

Front Psychiatry. 2018 Jun 5;9:178. doi: 10.3389/fpsyt.2018.00178. eCollection 2018. Review.

5.

A successful treatment for hepatocellular carcinoma with Osler-Rendu-Weber disease using radiofrequency ablation under laparoscopy.

Takaoka Y, Morimoto N, Miura K, Nomoto H, Murayama K, Hirosawa T, Watanabe S, Fujieda T, Ttsukui M, Kawata H, Niki T, Isoda N, Iijima M, Yamamoto H.

Clin J Gastroenterol. 2018 Jun 16. doi: 10.1007/s12328-018-0877-x. [Epub ahead of print]

PMID:
29909559
6.

Data on various allergen specific IgEs and prospective treatments on food-dependent exercise-induced anaphylaxis.

Murayama N, Murayama K.

Data Brief. 2018 May 5;18:1895-1899. doi: 10.1016/j.dib.2018.04.097. eCollection 2018 Jun.

7.

The Ventral Anterior Temporal Lobe has a Necessary Role in Exception Word Reading.

Ueno T, Meteyard L, Hoffman P, Murayama K.

Cereb Cortex. 2018 Aug 1;28(8):3035-3045. doi: 10.1093/cercor/bhy131.

8.

Nonerosive reflux disease: clinical concepts.

Gyawali CP, Azagury DE, Chan WW, Chandramohan SM, Clarke JO, de Bortoli N, Figueredo E, Fox M, Jodorkovsky D, Lazarescu A, Malfertheiner P, Martinek J, Murayama KM, Penagini R, Savarino E, Shetler KP, Stein E, Tatum RP, Wu J.

Ann N Y Acad Sci. 2018 May 15. doi: 10.1111/nyas.13845. [Epub ahead of print] Review.

PMID:
29761528
9.

Comparison of the Clinical Efficacy of Salbutamol with Jet and Mesh Nebulizers in Asthmatic Children.

Murayama N, Murayama K.

Pulm Med. 2018 Mar 13;2018:1648652. doi: 10.1155/2018/1648652. eCollection 2018.

10.

Mutations in COA7 cause spinocerebellar ataxia with axonal neuropathy.

Higuchi Y, Okunushi R, Hara T, Hashiguchi A, Yuan J, Yoshimura A, Murayama K, Ohtake A, Ando M, Hiramatsu Y, Ishihara S, Tanabe H, Okamoto Y, Matsuura E, Ueda T, Toda T, Yamashita S, Yamada K, Koide T, Yaguchi H, Mitsui J, Ishiura H, Yoshimura J, Doi K, Morishita S, Sato K, Nakagawa M, Yamaguchi M, Tsuji S, Takashima H.

Brain. 2018 Jun 1;141(6):1622-1636. doi: 10.1093/brain/awy104.

11.

High-level heteroplasmy for the m.7445A>G mitochondrial DNA mutation can cause progressive sensorineural hearing loss in infancy.

Matsushima K, Nakano A, Arimoto Y, Mutai H, Yamazawa K, Murayama K, Matsunaga T.

Int J Pediatr Otorhinolaryngol. 2018 May;108:125-131. doi: 10.1016/j.ijporl.2018.02.037. Epub 2018 Feb 27.

PMID:
29605341
12.

Bortezomib maintenance therapy in transplant-ineligible myeloma patients who plateaued after bortezomib-based induction therapy: a multicenter phase II clinical trial.

Isoda A, Murayama K, Ito S, Kohara Y, Iino M, Miyazawa Y, Matsumoto M, Handa H, Imai Y, Ishiguro T, Izumita W, Kitano K, Hirabayashi Y, Nakazawa H, Ishida F, Mitsumori T, Kirito K, Chou T, Murakami H; Kanshinetsu Multiple Myeloma Study Group.

Int J Hematol. 2018 Jul;108(1):39-46. doi: 10.1007/s12185-018-2448-9. Epub 2018 Mar 28.

PMID:
29594921
13.

Curiosity in old age: A possible key to achieving adaptive aging.

Sakaki M, Yagi A, Murayama K.

Neurosci Biobehav Rev. 2018 May;88:106-116. doi: 10.1016/j.neubiorev.2018.03.007. Epub 2018 Mar 12. Review.

PMID:
29545165
14.

Effectiveness of plasma lyso-Gb3 as a biomarker for selecting high-risk patients with Fabry disease from multispecialty clinics for genetic analysis.

Maruyama H, Miyata K, Mikame M, Taguchi A, Guili C, Shimura M, Murayama K, Inoue T, Yamamoto S, Sugimura K, Tamita K, Kawasaki T, Kajihara J, Onishi A, Sugiyama H, Sakai T, Murata I, Oda T, Toyoda S, Hanawa K, Fujimura T, Ura S, Matsumura M, Takano H, Yamashita S, Matsukura G, Tazawa R, Shiga T, Ebato M, Satoh H, Ishii S.

Genet Med. 2018 Mar 15. doi: 10.1038/gim.2018.31. [Epub ahead of print]

PMID:
29543226
15.

Leigh syndrome with spinal cord involvement due to a hemizygous NDUFA1 mutation.

Miyauchi A, Osaka H, Nagashima M, Kuwajima M, Monden Y, Kohda M, Kishita Y, Okazaki Y, Murayama K, Ohtake A, Yamagata T.

Brain Dev. 2018 Jun;40(6):498-502. doi: 10.1016/j.braindev.2018.02.007. Epub 2018 Mar 3.

PMID:
29506883
16.

MT-ND5 Mutation Exhibits Highly Variable Neurological Manifestations at Low Mutant Load.

Ng YS, Lax NZ, Maddison P, Alston CL, Blakely EL, Hepplewhite PD, Riordan G, Meldau S, Chinnery PF, Pierre G, Chronopoulou E, Du A, Hughes I, Morris AA, Kamakari S, Chrousos G, Rodenburg RJ, Saris CGJ, Feeney C, Hardy SA, Sakakibara T, Sudo A, Okazaki Y, Murayama K, Mundy H, Hanna MG, Ohtake A, Schaefer AM, Champion MP, Turnbull DM, Taylor RW, Pitceathly RDS, McFarland R, Gorman GS.

EBioMedicine. 2018 Apr;30:86-93. doi: 10.1016/j.ebiom.2018.02.010. Epub 2018 Feb 24.

17.

An infant case of diffuse cerebrospinal lesions and cardiomyopathy caused by a BOLA3 mutation.

Nishioka M, Inaba Y, Motobayashi M, Hara Y, Numata R, Amano Y, Shingu K, Yamamoto Y, Murayama K, Ohtake A, Nakazawa Y.

Brain Dev. 2018 Jun;40(6):484-488. doi: 10.1016/j.braindev.2018.02.004. Epub 2018 Mar 2.

PMID:
29501406
18.

Preliminary study of time maximum intensity projection computed tomography imaging for the detection of early ischemic change in patient with acute ischemic stroke.

Murayama K, Suzuki S, Matsukiyo R, Takenaka A, Hayakawa M, Tsutsumi T, Fujii K, Katada K, Toyama H.

Medicine (Baltimore). 2018 Mar;97(9):e9906. doi: 10.1097/MD.0000000000009906.

19.

Mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes with severe systemic symptoms: Pathology and biochemistry.

Kondo H, Fujita Y, Mizuno Y, Kihara M, Murayama K.

Pediatr Int. 2018 Mar;60(3):300-302. doi: 10.1111/ped.13472. Epub 2018 Feb 26. No abstract available.

PMID:
29480536
20.

Clinical management and outcomes of completely resected stage I follicular lymphoma.

Yokohama A, Hashimoto Y, Takizawa M, Shimizu H, Miyazawa Y, Saitoh A, Toyama K, Ishizaki T, Mitsui T; Hiromi; Koiso, Saitoh T, Murayama K, Matsumoto M, Sawamura M, Murakami H, Hirato J, Kojima M, Nojima Y, Handa H, Tsukamoto N.

J Clin Exp Hematop. 2018 Mar 16;58(1):10-16. doi: 10.3960/jslrt.17031. Epub 2018 Feb 8.

21.

Metabolic and chemical regulation of tRNA modification associated with taurine deficiency and human disease.

Asano K, Suzuki T, Saito A, Wei FY, Ikeuchi Y, Numata T, Tanaka R, Yamane Y, Yamamoto T, Goto T, Kishita Y, Murayama K, Ohtake A, Okazaki Y, Tomizawa K, Sakaguchi Y, Suzuki T.

Nucleic Acids Res. 2018 Feb 28;46(4):1565-1583. doi: 10.1093/nar/gky068.

22.

Do clinically anxious children cluster according to their expression of factors that maintain child anxiety?

Pearcey S, Alkozei A, Chakrabarti B, Dodd H, Murayama K, Stuijfzand S, Creswell C.

J Affect Disord. 2018 Mar 15;229:469-476. doi: 10.1016/j.jad.2017.12.078. Epub 2018 Jan 3.

23.

Loss of the Mitochondrial Fatty Acid β-Oxidation Protein Medium-Chain Acyl-Coenzyme A Dehydrogenase Disrupts Oxidative Phosphorylation Protein Complex Stability and Function.

Lim SC, Tajika M, Shimura M, Carey KT, Stroud DA, Murayama K, Ohtake A, McKenzie M.

Sci Rep. 2018 Jan 9;8(1):153. doi: 10.1038/s41598-017-18530-4.

24.

MPV17-related mitochondrial DNA maintenance defect: New cases and review of clinical, biochemical, and molecular aspects.

El-Hattab AW, Wang J, Dai H, Almannai M, Staufner C, Alfadhel M, Gambello MJ, Prasun P, Raza S, Lyons HJ, Afqi M, Saleh MAM, Faqeih EA, Alzaidan HI, Alshenqiti A, Flore LA, Hertecant J, Sacharow S, Barbouth DS, Murayama K, Shah AA, Lin HC, Wong LC.

Hum Mutat. 2018 Apr;39(4):461-470. doi: 10.1002/humu.23387. Epub 2018 Jan 13.

PMID:
29282788
25.
26.

Barth Syndrome: Different Approaches to Diagnosis.

Imai-Okazaki A, Kishita Y, Kohda M, Yatsuka Y, Hirata T, Mizuno Y, Harashima H, Hirono K, Ichida F, Noguchi A, Yoshida M, Tokorodani C, Nishiuchi R, Takeda A, Nakaya A, Sakata Y, Murayama K, Ohtake A, Okazaki Y.

J Pediatr. 2018 Feb;193:256-260. doi: 10.1016/j.jpeds.2017.09.075. Epub 2017 Dec 15.

PMID:
29249525
27.

A variant of death-receptor 3 associated with rheumatoid arthritis interferes with apoptosis-induction of T cell.

Hashiramoto A, Konishi Y, Murayama K, Kawasaki H, Yoshida K, Tsumiyama K, Tanaka K, Mizuhara M, Shiotsuki T, Kitamura H, Komai K, Kimura T, Yagita H, Shiozawa K, Shiozawa S.

J Biol Chem. 2018 Feb 9;293(6):1933-1943. doi: 10.1074/jbc.M117.798884. Epub 2017 Nov 27.

28.

An integrated model of academic self-concept development: Academic self-concept, grades, test scores, and tracking over 6 years.

Marsh HW, Pekrun R, Murayama K, Arens AK, Parker PD, Guo J, Dicke T.

Dev Psychol. 2018 Feb;54(2):263-280. doi: 10.1037/dev0000393. Epub 2017 Nov 27.

PMID:
29172566
29.

Remote intracranial recurrence of IDH mutant gliomas is associated with TP53 mutations and an 8q gain.

Nakae S, Kato T, Murayama K, Sasaki H, Abe M, Kumon M, Kumai T, Yamashiro K, Inamasu J, Hasegawa M, Kurahashi H, Hirose Y.

Oncotarget. 2017 Sep 15;8(49):84729-84742. doi: 10.18632/oncotarget.20951. eCollection 2017 Oct 17.

30.

Impaired prefrontal activity to regulate the intrinsic motivation-action link in schizophrenia.

Takeda K, Matsumoto M, Ogata Y, Maida K, Murakami H, Murayama K, Shimoji K, Hanakawa T, Matsumoto K, Nakagome K.

Neuroimage Clin. 2017 Jul 4;16:32-42. doi: 10.1016/j.nicl.2017.07.003. eCollection 2017.

31.
32.

Increase in proapoptotic activity of inhibitory PAS domain protein via phosphorylation by MK2.

Kasai S, Richardson MJE, Torii S, Yasumoto KI, Shima H, Igarashi K, Itoh K, Sogawa K, Murayama K.

FEBS J. 2017 Dec;284(23):4115-4127. doi: 10.1111/febs.14300. Epub 2017 Nov 13.

PMID:
29054108
33.

Novel Application of Time-Spatial Labeling Inversion Pulse Magnetic Resonance Imaging for Diagnosis of External Hydrocephalus.

Nakae S, Murayama K, Adachi K, Kumai T, Abe M, Hirose Y.

World Neurosurg. 2018 Jan;109:197-201. doi: 10.1016/j.wneu.2017.09.175. Epub 2017 Oct 5.

PMID:
28989050
34.

A prospective study of the motivational and health dynamics of Internet Gaming Disorder.

Weinstein N, Przybylski AK, Murayama K.

PeerJ. 2017 Sep 29;5:e3838. doi: 10.7717/peerj.3838. eCollection 2017.

35.

Biallelic C1QBP Mutations Cause Severe Neonatal-, Childhood-, or Later-Onset Cardiomyopathy Associated with Combined Respiratory-Chain Deficiencies.

Feichtinger RG, Oláhová M, Kishita Y, Garone C, Kremer LS, Yagi M, Uchiumi T, Jourdain AA, Thompson K, D'Souza AR, Kopajtich R, Alston CL, Koch J, Sperl W, Mastantuono E, Strom TM, Wortmann SB, Meitinger T, Pierre G, Chinnery PF, Chrzanowska-Lightowlers ZM, Lightowlers RN, DiMauro S, Calvo SE, Mootha VK, Moggio M, Sciacco M, Comi GP, Ronchi D, Murayama K, Ohtake A, Rebelo-Guiomar P, Kohda M, Kang D, Mayr JA, Taylor RW, Okazaki Y, Minczuk M, Prokisch H.

Am J Hum Genet. 2017 Oct 5;101(4):525-538. doi: 10.1016/j.ajhg.2017.08.015. Epub 2017 Sep 21.

36.

Japanese Leigh syndrome case treated with EPI-743.

Kouga T, Takagi M, Miyauchi A, Shimbo H, Iai M, Yamashita S, Murayama K, Klein MB, Miller G, Goto T, Osaka H.

Brain Dev. 2018 Feb;40(2):145-149. doi: 10.1016/j.braindev.2017.08.005. Epub 2017 Sep 12.

PMID:
28916229
37.

Re-evaluation of glycated hemoglobin and glycated albumin with continuous glucose monitoring system as markers of glycemia in patients with liver cirrhosis.

Isoda H, Takahashi H, Eguchi Y, Kojima M, Inoue K, Murayama K, Matsuda Y, Anzai K.

Biomed Rep. 2017 Sep;7(3):286. doi: 10.3892/br.2017.928. Epub 2017 Jun 16.

38.

Introduction of 2,6-Diaminopurines into Serinol Nucleic Acid Improves Anti-miRNA Performance.

Kamiya Y, Donoshita Y, Kamimoto H, Murayama K, Ariyoshi J, Asanuma H.

Chembiochem. 2017 Oct 5;18(19):1917-1922. doi: 10.1002/cbic.201700272. Epub 2017 Aug 22.

PMID:
28748559
39.

Supplementation with branched-chain amino acids ameliorates hypoalbuminemia, prevents sarcopenia, and reduces fat accumulation in the skeletal muscles of patients with liver cirrhosis.

Kitajima Y, Takahashi H, Akiyama T, Murayama K, Iwane S, Kuwashiro T, Tanaka K, Kawazoe S, Ono N, Eguchi T, Anzai K, Eguchi Y.

J Gastroenterol. 2018 Mar;53(3):427-437. doi: 10.1007/s00535-017-1370-x. Epub 2017 Jul 24.

PMID:
28741271
40.

Solid State Structures of Lead Complexes with Relevance for Biological Systems.

Aoki K, Murayama K, Hu NH.

Met Ions Life Sci. 2017 Apr 10;17. pii: /books/9783110434330/9783110434330-007/9783110434330-007.xml. doi: 10.1515/9783110434330-007.

PMID:
28731300
41.

HDR-del: A tool based on Hamming distance for prioritizing pathogenic chromosomal deletions in exome sequencing.

Imai-Okazaki A, Kohda M, Kobayashi K, Hirata T, Sakata Y, Murayama K, Ohtake A, Okazaki Y, Nakaya A, Ott J.

Hum Mutat. 2017 Dec;38(12):1796-1800. doi: 10.1002/humu.23298. Epub 2017 Sep 21.

PMID:
28722338
42.

Retrospective analysis of prognostic factors for Waldenstrӧm macroglobulinemia: a multicenter cooperative study in Japan.

Saito A, Isoda A, Kojima M, Yokohama A, Tsukune Y, Sasaki M, Ito S, Ohtsu A, Koike M, Murayama K, Moriya K, Tamura H, Matsumoto M, Nakahashi H, Tanosaki S, Sakura T, Kawamura T, Miyanaga T, Nakamura N, Murakami H, Handa H, Tsukamoto N.

Int J Hematol. 2017 Nov;106(5):681-690. doi: 10.1007/s12185-017-2297-y. Epub 2017 Jul 7.

PMID:
28687991
43.

Novel biallelic mutations in the PNPT1 gene encoding a mitochondrial-RNA-import protein PNPase cause delayed myelination.

Sato R, Arai-Ichinoi N, Kikuchi A, Matsuhashi T, Numata-Uematsu Y, Uematsu M, Fujii Y, Murayama K, Ohtake A, Abe T, Kure S.

Clin Genet. 2018 Feb;93(2):242-247. doi: 10.1111/cge.13068. Epub 2017 Oct 4.

PMID:
28594066
44.

The standard international prognostic index for predicting the risk of CNS involvement in DLBCL without specific prophylaxis.

Tomita N, Yokoyama M, Yamamoto W, Watanabe R, Shimazu Y, Masaki Y, Tsunoda S, Hashimoto C, Murayama K, Yano T, Okamoto R, Kikuchi A, Tamura K, Sato K, Sunami K, Shibayama H, Takimoto R, Ohshima R, Takahashi H, Moriuchi Y, Kinoshita T, Yamamoto M, Numata A, Nakajima H, Miura I, Takeuchi K.

Leuk Lymphoma. 2018 Jan;59(1):97-104. doi: 10.1080/10428194.2017.1330541. Epub 2017 Jun 8.

PMID:
28593796
45.

Liver Transplantation for Mitochondrial Respiratory Chain Disorder: A Single-Center Experience and Excellent Marker of Differential Diagnosis.

Sasaki K, Sakamoto S, Uchida H, Narumoto S, Shigeta T, Fukuda A, Ito R, Irie R, Yoshioka T, Murayama K, Kasahara M.

Transplant Proc. 2017 Jun;49(5):1097-1102. doi: 10.1016/j.transproceed.2017.03.065.

PMID:
28583535
46.

ATAD3 gene cluster deletions cause cerebellar dysfunction associated with altered mitochondrial DNA and cholesterol metabolism.

Desai R, Frazier AE, Durigon R, Patel H, Jones AW, Dalla Rosa I, Lake NJ, Compton AG, Mountford HS, Tucker EJ, Mitchell ALR, Jackson D, Sesay A, Di Re M, van den Heuvel LP, Burke D, Francis D, Lunke S, McGillivray G, Mandelstam S, Mochel F, Keren B, Jardel C, Turner AM, Ian Andrews P, Smeitink J, Spelbrink JN, Heales SJ, Kohda M, Ohtake A, Murayama K, Okazaki Y, Lombès A, Holt IJ, Thorburn DR, Spinazzola A.

Brain. 2017 Jun 1;140(6):1595-1610. doi: 10.1093/brain/awx094.

47.

Negative conversion of high serum p53 antibody titers in a patient with gastric cancer at 31 months after surgery.

Murayama K, Nanami T, Suzuki T, Oshima Y, Yajima S, Nemoto T, Shimada H.

Clin J Gastroenterol. 2017 Aug;10(4):357-360. doi: 10.1007/s12328-017-0749-9. Epub 2017 May 24.

PMID:
28540696
48.

Differentiating between Central Nervous System Lymphoma and High-grade Glioma Using Dynamic Susceptibility Contrast and Dynamic Contrast-enhanced MR Imaging with Histogram Analysis.

Murayama K, Nishiyama Y, Hirose Y, Abe M, Ohyu S, Ninomiya A, Fukuba T, Katada K, Toyama H.

Magn Reson Med Sci. 2018 Jan 10;17(1):42-49. doi: 10.2463/mrms.mp.2016-0113. Epub 2017 May 18.

49.

Induction of Pluripotent Stem Cells from a Manifesting Carrier of Duchenne Muscular Dystrophy and Characterization of Their X-Inactivation Status.

Miyagoe-Suzuki Y, Nishiyama T, Nakamura M, Narita A, Takemura F, Masuda S, Minami N, Murayama K, Komaki H, Goto YI, Takeda S.

Stem Cells Int. 2017;2017:7906843. doi: 10.1155/2017/7906843. Epub 2017 Apr 12.

50.

Deposition Dosages of Three Cromolyn Forms by Cascade Impactor.

Murayama N, Asai K, Murayama K, Kitatsuji C, Doi S.

J Drug Deliv. 2017;2017:1892725. doi: 10.1155/2017/1892725. Epub 2017 Apr 2.

Supplemental Content

Loading ...
Support Center